Education
About Us
Working with TipRanks
Follow Us
Danaher Corporation (DHR)
NYSE:DHR
DHR Stock Chart & Stats
$230.32
-$1.72(-0.72%)
At close: 4:00 PM EST
$230.32
-$1.72(-0.72%)
Day’s Range― - ―
52-Week Range$171.00 - $258.23
Previous CloseN/A
Volume816.38K
Average Volume (3M)3.68M
Market Cap
$162.69B
Enterprise Value$148.56B
Total Cash (Recent Filing)$1.53B
Total Debt (Recent Filing)$16.86B
Price to Earnings (P/E)47.4
Beta0.83
Next Earnings
Jan 28, 2026EPS Estimate
2.14Next Dividend Ex-DateN/A
Dividend Yield0.53%
Share Statistics
EPS (TTM)1.89
Shares Outstanding706,349,550
10 Day Avg. Volume3,859,913
30 Day Avg. Volume3,681,742
Financial Highlights & Ratios
PEG Ratio-2.50
Price to Book (P/B)3.39
Price to Sales (P/S)7.03
P/FCF Ratio31.68
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue6.12
Enterprise Value/Gross Profit9.97
Enterprise Value/Ebitda21.64
Forecast
1Y Price Target
$256.13Price Target Upside11.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)7.71
Revenue Forecast (FY)$24.52B
Bulls Say, Bears Say
Bulls Say
Cost ManagementProactive cost management and reinvestment strategies are paving the way for Danaher's earnings growth, providing a cleaner entry point for investors.
Earnings PerformanceDanaher reported strong third-quarter results with revenues surpassing expectations and significant earnings per share growth.
Market PositionDespite the reduction in sales forecast, analysts maintain a Buy rating, expressing confidence in Danaher's market position and execution capabilities.
Bears Say
Growth GuidanceDanaher has lowered its 2025 non-GAAP core revenue growth guidance, implying a reduction to low single-digit growth.
Organic Sales ForecastThe forecast for fiscal year 2025 organic sales has been reduced, which is seen as disappointing by analysts.
Segment WeaknessesWeak spots exist in Life Sciences and China Diagnostics, which are assumed in the guide.
Danaher News
DHR FAQ
What was Danaher Corporation’s price range in the past 12 months?
Danaher Corporation lowest stock price was $171.00 and its highest was $258.23 in the past 12 months.
What is Danaher Corporation’s market cap?
Danaher Corporation’s market cap is $162.69B.
When is Danaher Corporation’s upcoming earnings report date?
Danaher Corporation’s upcoming earnings report date is Jan 28, 2026 which is in 31 days.
How were Danaher Corporation’s earnings last quarter?
Danaher Corporation released its earnings results on Oct 21, 2025. The company reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.722 by $0.168.
Is Danaher Corporation overvalued?
According to Wall Street analysts Danaher Corporation’s price is currently Undervalued.
Does Danaher Corporation pay dividends?
Danaher Corporation pays a Quarterly dividend of $0.32 which represents an annual dividend yield of 0.53%. See more information on Danaher Corporation dividends here
What is Danaher Corporation’s EPS estimate?
Danaher Corporation’s EPS estimate is 2.14.
How many shares outstanding does Danaher Corporation have?
Danaher Corporation has 706,349,550 shares outstanding.
What happened to Danaher Corporation’s price movement after its last earnings report?
Danaher Corporation reported an EPS of $1.89 in its last earnings report, beating expectations of $1.722. Following the earnings report the stock price went up 5.939%.
Which hedge fund is a major shareholder of Danaher Corporation?
Currently, no hedge funds are holding shares in DHR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Danaher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$256.13 (11.21% Upside)
$256.13 (11.21% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 70%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 5.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $244.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.32%
12-Months-Change
Fundamentals
Return on Equity
6.84%
Trailing 12-Months
Asset Growth
-0.89%
Trailing 12-Months
Company Description
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
DHR Company Deck
DHR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Danaher Corporation reported strong financial performance with notable growth in the bioprocessing segment and successful new product launches. However, challenges in China and a decline in Life Sciences and equipment revenue were highlighted as areas of concern. Overall, the company is optimistic about overcoming these challenges and maintains a positive outlook for the future.View all DHR earnings summariesDHR Revenue Breakdown
28.31% Biotechnology
30.70% Life Sciences
40.99% Diagnostics
DHR Stock 12 Month Forecast
Average Price Target
$256.13
▲(11.21% Upside)
Technical Analysis
Ownership Overview
8.74% Insiders
25.97% Mutual Funds
24.01% Other Institutional Investors
21.09% Public Companies and Individual Investors